Someit Sidhu - 31 Dec 2024 Form 5 Insider Report for Zura Bio Ltd (ZURA)

Footnote F1

The shares were distributed by the Reporting Person to JATT Ventures, L.P. ("JATT") directors for no additional consideration.

Footnote F2

JATT distributed Class A ordinary shares to its members with no consideration being paid in connection therewith.

Footnote F3

These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT.

Footnote F4

JATT transferred Class A ordinary shares to Willow Gate, LLC for no additional consideration.

Footnote F5

The reported warrants were exchanged for Class A Ordinary Shares ("Ordinary Shares") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference.

Footnote F6

These shares are beneficially owned by Pegasus LLC. The Reporting Person is the sole member and beneficial owner of the limited liability company interests of Pegasus LLC.

Footnote F7

JATT distributed private placement warrants to its members with no consideration being paid in connection therewith.

Footnote F8

The warrants were distributed by JATT to the Reporting Person for no additional consideration.

Footnote F9

The warrants were purchased by way of a private transaction.